Skip to main content

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Stryker Secur-Fit & C-Taper LFit Linked To Design Defects

Introduction

In a recently filed product liability lawsuit, Stryker Howmedica Osteonics Corporation's hip implant component Secur-Fit femoral stem and C-Taper LFit femoral head were reported to be defectively designed and prone to corrosion. The lawsuit was filed by a couple on September 13 in the U.S. District Court for the District of Minnesota and indicates the implant is unreasonably risky.

The man underwent a left total hip arthroplasty in January 2011, and within a year of the surgery, he started developing pain and stiffness in the hip. After undergoing a revision surgery in October 2016, he suffered severe tissue necrosis and black sludge corrosion at the interface of the trunnion interface. The complaint filed states, the combination of a titanium alloy stem with a cobalt/chromium femoral head is known to cause fretting and corrosion, which was ignored by the manufacturer. Stryker faces hundreds of product liability lawsuits linked to complications of its LFit hip implant. Lawsuits associated with Stryker LFit components have been centralized for coordinated pretrial proceedings in the U.S. District Court for the District of Massachusetts overlooked by Judge Indira Talwani. The first bellwether trial has been scheduled to commence in September 2019.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.